When should we treat children with hiv? Reportar como inadecuado




When should we treat children with hiv? - Descarga este documento en PDF. Documentación en PDF para descargar gratis. Disponible también para leer online.

Jornal de Pediatria 2006, 82 4

Autor: James M. Oleske

Fuente: http://www.redalyc.org/articulo.oa?id=399738113002


Introducción



Jornal de Pediatria ISSN: 0021-7557 assessoria@jped.com.br Sociedade Brasileira de Pediatria Brasil Oleske, James M. When should we treat children with HIV? Jornal de Pediatria, vol.
82, núm.
4, julio-agosto, 2006, pp.
243-245 Sociedade Brasileira de Pediatria Porto Alegre, Brasil Available in: http:--www.redalyc.org-articulo.oa?id=399738113002 How to cite Complete issue More information about this article Journals homepage in redalyc.org Scientific Information System Network of Scientific Journals from Latin America, the Caribbean, Spain and Portugal Non-profit academic project, developed under the open access initiative Jornal de Pediatria - Vol.
82, No.4, 2006 243 When should we treat children with HIV? – Oleske JM When should we treat children with HIV? James M.
Oleske* Romanelli et al.
have reviewed the evolution of In infants who are found to be HIV-infected, the early antiretroviral (ARV) therapy implemented between January institution of antiretroviral regimens has become the 1998 and December 2001 at Universidade Federal de standard of care to reduce mortality and the development Minas Gerais (UFMG) and concluded that triple drug of resistance mutations while preserving immunologic regimens were more effective than dual drug therapy.1 function.4,5 There are a number of issues that make Their conclusion mirrors, in part, US pediatric guidelines treatment of HIV more problematic in the pediatric age for antiretroviral therapy in HIV- group.
These include the timing of HIV infected children.
Initially developed infection in infants, which occurs when in 1993, these guidelines have been their immune systems are developing updated periodically (last update: March 11, 2005) by the Working Group on Antiretroviral Therapy and Medical See related article on page 260 and more susceptible to the negative consequences of HIV infection.
The pharmacokinetics of the multiple drugs HIV-Infected used in the treatment of HIV varies as Chil...





Documentos relacionados